Safety Evaluation of Biotechnology Products

This publication has 21 references indexed in Scilit:

• TOXICITY OF HUMAN RECOMBINANT INTERLEUKIN-2 IN RATS - PATHOLOGIC-CHANGES ARE CHARACTERIZED BY MARKED LYMPHOCYTIC AND EOSINOPHILIC PROLIFERATION AND MULTISYSTEM INVOLVEMENT
  1989
• Repetitive Weekly Cycles of Interleukin-2. II. Clinical and Immunologic Effects of Dose, Schedule, and Addition of Indomethacin
  JNCI Journal of the National Cancer Institute, 1988
• TOXICITY OF HUMAN RECOMBINANT INTERLEUKIN-2 IN THE MOUSE IS MEDIATED BY INTERLEUKIN-ACTIVATED LYMPHOCYTES - SEPARATION OF EFFICACY AND TOXICITY BY SELECTIVE LYMPHOCYTE SUBSET DEPLETION
  1988
• A Molecular Basis for MHC Class II—Associated Autoimmunity
  Science, 1988
• CLINICAL AND IMMUNOLOGICAL EFFECTS OF RECOMBINANT INTERLEUKIN-2 GIVEN BY REPETITIVE WEEKLY CYCLES TO PATIENTS WITH CANCER
  1988
• Biotechnology products intended for human use, toxicological targets and research strategies.
  1987
• Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon.
  The Journal of Experimental Medicine, 1985
• Coagulopathy induced by continuous infusion of high doses of human lymphoblastoid interferon.
  1985
• ADVERSE-EFFECTS OF INTERFERON TREATMENT ON THE LIFE-SPAN OF NZB MICE
  1979
• New method for detection and quantitation of circulating platelet aggregates
  Microvascular Research, 1972